Alzheimer's and dementia drug trial halted before it began
NCT ID NCT02467413
First seen May 21, 2026 · Last updated May 24, 2026 · Updated 1 time
Summary
This study aimed to test a drug called BAC in people with Alzheimer's disease or vascular dementia. The goal was to see if BAC could improve thinking and memory, and to check for side effects. However, the trial was withdrawn before any participants were enrolled, so no results are available.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ALZHEIMER'S DISEASE are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
National Cheng Kung University Hospital
Tainan, 704, Taiwan
Conditions
Explore the condition pages connected to this study.